Altimmune
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Altimmune generated cash of -$75,810,000, which is less than the previous year. Cash used in financing activities reached the amount of $86,105,000 last year. Net change in cash is therefore $24,027,000.
Cash Flow
| 2014 | -8.47M | -84.26K | 16.73M |
|---|---|---|---|
| 2015 | -3.21M | -78.90K | 223.12K |
| 2016 | 201.50M | -66.87M | 3.80M |
| 2017 | -20.21M | 13.72M | 15.84M |
| 2018 | -9.38M | -1.00M | 32.48M |
| 2019 | -9.60M | -28.28M | 12.53M |
| 2020 | -34.43M | -72.09M | 213.48M |
| 2021 | -78.23M | 87.52M | 65.09M |
| 2022 | -62.58M | -73.39M | 56.78M |
| 2023 | -75.81M | 13.73M | 86.10M |
ALT Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 111.13M | 190.33M | 115.95M | 8.99M | 34.35M | 12.30M | 2.87M | 15.56M | 18.64M | 10.48M |
Operating activities | ||||||||||
Net income | -88.44M | -84.71M | -97.09M | -49.04M | -20.52M | -39.17M | -46.42M | 193.85M | -3.44M | -9.95M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 477K | -205K | 551.30K | 298.05K | 387.32K | 302.36K | 139.01K | 143.43K | 141.60K | 149.95K |
Stock-based compensation expense | 10.64M | 8.10M | 5.51M | 2.57M | 1.26M | 0 | 1.44M | 2.24M | 613.01K | 1.65M |
| Deferred income tax benefit | 10.64M | 8.10M | 5.51M | 2.57M | 1.26M | 0 | 1.44M | 2.24M | 613.01K | 1.65M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -2.31M | 256K | 4.18M | -3.58M | 2.44M | 344.30K | -1.94M | 476.19K | -1.06M | 3.21M |
Inventories | 1 | 0 | 0 | 0 | -288.80K | 5.59M | -4.12M | 3.26M | -14.61M | -2.09M |
Accounts payable | -2.73M | 2.77M | 1.42M | 594.06K | -354.62K | 243.06K | -2.62M | 405.40K | 129.72K | -736.77K |
Cash generated by operating activities | -75.81M | -62.58M | -78.23M | -34.43M | -9.60M | -9.38M | -20.21M | 201.50M | -3.21M | -8.47M |
Investing activities | ||||||||||
Purchases Of Investments | -88.63M | -73.27M | -7.59M | -128.15M | -28.25M | 0 | 0 | -66.84M | 0 | 0 |
Investments In Property Plant And Equipment | -47K | -126K | -12.31M | -342.42K | -28.99K | -1.01M | -166.32K | -30.68K | -86.50K | -92.26K |
Acquisitions Net | 0 | 0 | 194.53K | 138.46K | 0 | 14.49K | 13.68M | 0 | 7.6K | 0 |
Cash generated by investing activities | 13.73M | -73.39M | 87.52M | -72.09M | -28.28M | -1.00M | 13.72M | -66.87M | -78.90K | -84.26K |
Financing activities | ||||||||||
Common Stock Issued | 86.81M | 56.34M | 65.21M | 213.48M | 12.66M | 37.40M | 13.01B | 3.80M | 973.13K | 18.14M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 215K | 0 | 0 | 0 | 0 | -2.38M | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | -632K | 0 | -1.54M | 2.80M | -80.56K | -750.00K | -999.99B |
Cash used in financing activities | 86.10M | 56.78M | 65.09M | 213.48M | 12.53M | 32.48M | 15.84M | 3.80M | 223.12K | 16.73M |
Net Change In Cash | 24.02M | -79.20M | 74.38M | 106.95M | -25.35M | 22.04M | 9.42M | 138.42M | -3.07M | 8.16M |
Cash at end of period | 135.15M | 111.13M | 190.33M | 115.95M | 8.99M | 34.35M | 12.30M | 153.99M | 15.56M | 18.64M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |